Bioplex analysis of plasma cytokines in Alzheimer’s disease and mild cognitive impairment

Saved in:
Bibliographic Details
Title: Bioplex analysis of plasma cytokines in Alzheimer’s disease and mild cognitive impairment
Authors: Ji Hyung Chung, Byoung Hoon Oh, Min Jeong Shin, Kyung Hye Lee, Kang Soo Lee, Chang Hyung Hong
Contributors: Kang Soo Lee, Ji Hyung Chung, Kyung Hye Lee, Min-Jeong Shin, Byoung Hoon Oh, Chang Hyung Hong, Oh, Byong Hoon
Source: Immunology Letters. 121:105-109
Publisher Information: Elsevier BV, 2008.
Publication Year: 2008
Subject Terms: Alzheimer Disease/diagnosis, Cognition Disorders/diagnosis, Male, Polymers, Macrophage Migration-Inhibitory Factors/blood, Chemokine CXCL9/immunology, Enzyme-Linked Immunosorbent Assay, Cognition Disorders/blood, Cognition Disorders/immunology, Cytokines/blood, Chemokine CXCL9, 03 medical and health sciences, Cytokines/immunology, 0302 clinical medicine, Alzheimer Disease/psychology, Alzheimer Disease, 80 and over, Humans, Macrophage Migration-Inhibitory Factors/immunology, Macrophage Migration-Inhibitory Factors, Alzheimer Disease/immunology, Aged, Aged, 80 and over, Gene Expression Regulation/immunology, Cytokines/genetics, Alzheimer Disease/blood, Cognition Disorders/psychology, Intramolecular Oxidoreductases/genetics, Prognosis, 3. Good health, Intramolecular Oxidoreductases, Chemokine CXCL9/genetics, Gene Expression Regulation, Intramolecular Oxidoreductases/immunology, Macrophage Migration-Inhibitory Factors/genetics, Disease Progression, Cytokines, Intramolecular Oxidoreductases/blood, Female, Chemokine CXCL9/blood, Cognition Disorders, Biomarkers/blood, Biomarkers
Description: Inflammatory mechanisms within the central nervous system contribute to cognitive impairment via cytokine-mediated interactions between neurons and glial cells. Sixty-nine subjects were consecutively recruited from October 2005 to February 2007. Fifteen individuals were excluded from the study and we ultimately enrolled 19 not cognitively impaired subjects, 25 mild cognitive impairment patients, and 10 Alzheimer's disease patients. To examine the inflammatory markers of mild cognitive impairment and Alzheimer's disease, we measured the plasma concentrations of 23 cytokines using a bioplex assay. The results showed that the macrophage migration inhibitory factor was higher in mild cognitive impairment and in Alzheimer's disease patients compared with the not cognitively impaired group; the results also showed that monokine induced by gamma interferon was higher in Alzheimer's disease patients than in not cognitively impaired subjects, as well as those of the mild cognitive impairment group [corrected].
Document Type: Article
File Description: 105~109
Language: English
ISSN: 0165-2478
DOI: 10.1016/j.imlet.2008.09.004
Access URL: https://pubmed.ncbi.nlm.nih.gov/18930766
https://koreauniv.pure.elsevier.com/en/publications/bioplex-analysis-of-plasma-cytokines-in-alzheimers-disease-and-mi
http://repository.ajou.ac.kr/handle/201003/823?mode=simple
https://www.sciencedirect.com/science/article/pii/S0165247808002186
https://www.sciencedirect.com/science/article/abs/pii/S0165247808002186#!
https://pubmed.ncbi.nlm.nih.gov/18930766/
http://www.sciencedirect.com/science/article/pii/S0165247808002186
Rights: Elsevier TDM
CC BY NC ND
Accession Number: edsair.doi.dedup.....b7a87a0789643f92cb4486cfec4de4ae
Database: OpenAIRE
Description
Abstract:Inflammatory mechanisms within the central nervous system contribute to cognitive impairment via cytokine-mediated interactions between neurons and glial cells. Sixty-nine subjects were consecutively recruited from October 2005 to February 2007. Fifteen individuals were excluded from the study and we ultimately enrolled 19 not cognitively impaired subjects, 25 mild cognitive impairment patients, and 10 Alzheimer's disease patients. To examine the inflammatory markers of mild cognitive impairment and Alzheimer's disease, we measured the plasma concentrations of 23 cytokines using a bioplex assay. The results showed that the macrophage migration inhibitory factor was higher in mild cognitive impairment and in Alzheimer's disease patients compared with the not cognitively impaired group; the results also showed that monokine induced by gamma interferon was higher in Alzheimer's disease patients than in not cognitively impaired subjects, as well as those of the mild cognitive impairment group [corrected].
ISSN:01652478
DOI:10.1016/j.imlet.2008.09.004